Patent · US Active

Fused heterocyclic compound

US11390634B2 · kind B2 · utility

0Cited by
3References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2020
Grant dateJul 19, 2022
Priority date—
Expiry dateDec 22, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a compound represented by the following formula, or a salt thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.